| Literature DB >> 28962379 |
S Sánchez1, B Vera2,1, C Montagna2,3, G Magnarelli2,1.
Abstract
Although non-innervated, the placenta contains both cholinesterases (ChEs), butyrylcholinesterase (BChE) and acetylcholinesterase (AChE). These enzymes are well-known for their multiple molecular forms. In a first approach, we used recognized specific inhibitors, substrate preferences and non-denaturating gel electrophoresis in order to characterize the ChE profile of term placenta from uncomplicated pregnancy. Results strongly suggest that the predominant cholinesterasic form present was tetrameric BChE. It is well established that both ChEs are targets of cholinesterase-inhibiting organophosphates (OP), one of the most important classes of chemicals actively applied to the environment. However, we have previously reported increased ChEs activity in placenta of rural residents exposed to OP. In the present work, we have studied: 1) whether this finding was reproducible and, 2) whether AChE or BChE up regulation is behind the increase of placental ChE activity. The population studied included forty healthy women who live in an agricultural area. Samples were collected during both the OP pulverization period (PP) and the recess period (RP). The placental ChEs activity increased in PP, evidencing reproducibility of previous results. The analysis of non-denaturating gels revealed that increased activity of total ChE activity in placenta from women exposed to OP may be attributable to tetrameric BChE up-regulation.Entities:
Keywords: ACh, acetylcholine; AChE, acetylcholinesterase; ASCh, acetylthiocholine iodide; Acetylcholinesterase; BChE, butyrylcholinesterase; BSCh, butyrylthiocholine iodide; BW284C51, 1,5-bis (4-allyldimethyl ammoniumphenyl)-pentan-3-one dibromide; Butyrylcholinesterase; ChE, cholinesterase; ChEs, cholinesterases; OP, organophosphates; Organophosphates; PP, pulverization period; Placenta; RP, recess period; iso-OMPA, tetraisopropylpyrophosphoramide
Year: 2014 PMID: 28962379 PMCID: PMC5598449 DOI: 10.1016/j.toxrep.2014.11.013
Source DB: PubMed Journal: Toxicol Rep ISSN: 2214-7500
Fig. 1Effect of specific inhibitors of cholinesterase activity. Activity was determined by the Ellman assay using ASCh 0.48 mM as substrate. Results are presented as means ± SD of three placenta samples (s1, s2 and s3) in triplicates each of them. ANOVA: ***p < 0.0001.
Fig. 2Substrate preference of cholinesterases from total placenta homogenates. Results are presented as means ± SD of three placenta samples in triplicates each of them. ASCh vs. BSCh: t-test **p < 0.05.
Fig. 3Non-denaturing gel stained for activity with BSCh (A) and ASCh(B).
(A) and (B) line 1, AChE Electric Eel. Lines 2 and 5, human plasma samples. Lines 3 and 4, placenta homogenate samples. The band labeled BChE-alb is a disulfide-bonded dimer between one subunit of BChE and one molecule of albumin.
The results were expressed as mean ± SD.
| Cholinesterase activity | |
|---|---|
| RP ( | 9.28 ± 4.99 |
| PP ( | 16.34 ± 5.51 |
Cholinesterase activity in placenta homogenate was expressed as μmol of substrate hydrolyzed/mg protein−1 min−1. Activity was determined by the Ellman assay using ASCh 0.48 mM as substrate.
p < 0.001, t-test.
Fig. 4(A) Non-denaturing gel stained for activity with ASCh. Line 1, placenta homogenate sample (RP). Lines 2 and 3 homogenate samples (PP). Lines 4 and 5 human plasma samples and line 6 AChE Electric Eel. (B) The bar graph represents the densitometry quantification of protein levels in the placenta homogenates. Values obtained for the optical densities were: 0.29; 0.53 and 0.43.